Hammarlund-Udenaes M - Search Results

1

Interchangeability and predictive performance of empirical tolerance models.

Gårdmark M, Brynne L, Hammarlund-Udenaes M, Karlsson MO. Gårdmark M, et al. Clin Pharmacokinet. 1999 Feb;36(2):145-67. doi: 10.2165/00003088-199936020-00005. Clin Pharmacokinet. 1999. PMID: 10092960 Review.

2

Pharmacokinetics of raclopride formulations. Influence of prolactin and tolerability in healthy male volunteers.

Movin-Osswald G, Nordström AL, Hammarlund-Udenaes M, Wahlén A, Farde L. Movin-Osswald G, et al. Clin Pharmacokinet. 1992 Feb;22(2):152-61. doi: 10.2165/00003088-199222020-00006. Clin Pharmacokinet. 1992. PMID: 1551292

3

Estimation of unbound concentrations of morphine from microdialysate concentrations by use of nonlinear regression analysis in vivo and in vitro during steady state conditions.

Ekblom M, Gårdmark M, Hammarlund-Udenaes M. Ekblom M, et al. Life Sci. 1992;51(6):449-60. doi: 10.1016/0024-3205(92)90413-j. Life Sci. 1992. PMID: 1635423

4

Quantification of effect delay and acute tolerance development to morphine in the rat.

Gårdmark M, Ekblom M, Bouw R, Hammarlund-Udenaes M. Gårdmark M, et al. J Pharmacol Exp Ther. 1993 Dec;267(3):1061-7. J Pharmacol Exp Ther. 1993. PMID: 8263765

5

Pharmacokinetics and pharmacodynamics of morphine-3-glucuronide in rats and its influence on the antinociceptive effect of morphine.

Ekblom M, Gårdmark M, Hammarlund-Udenaes M. Ekblom M, et al. Biopharm Drug Dispos. 1993 Jan;14(1):1-11. doi: 10.1002/bdd.2510140102. Biopharm Drug Dispos. 1993. PMID: 8427941

6

Delayed antinociceptive effect following morphine-6-glucuronide administration in the rat--pharmacokinetic/pharmacodynamic modelling.

Gårdmark M, Hammarlund-Udenaes M. Gårdmark M, et al. Pain. 1998 Feb;74(2-3):287-96. doi: 10.1016/s0304-3959(97)00180-2. Pain. 1998. PMID: 9520243

7

Morphine-3-glucuronide has a minor effect on morphine antinociception. Pharmacodynamic modeling.

Gardmark M, Karlsson MO, Jonsson F, Hammarlund-Udenaes M. Gardmark M, et al. J Pharm Sci. 1998 Jul;87(7):813-20. doi: 10.1021/js980056f. J Pharm Sci. 1998. PMID: 9649348

8

Aspects on tail-flick, hot-plate and electrical stimulation tests for morphine antinociception.

Gårdmark M, Höglund AU, Hammarlund-Udenaes M. Gårdmark M, et al. Pharmacol Toxicol. 1998 Dec;83(6):252-8. doi: 10.1111/j.1600-0773.1998.tb01478.x. Pharmacol Toxicol. 1998. PMID: 9868743

9

A model for the turnover of dihydrotestosterone in the presence of the irreversible 5 alpha-reductase inhibitors GI198745 and finasteride.

Gisleskog PO, Hermann D, Hammarlund-Udenaes M, Karlsson MO. Gisleskog PO, et al. Clin Pharmacol Ther. 1998 Dec;64(6):636-47. doi: 10.1016/S0009-9236(98)90054-6. Clin Pharmacol Ther. 1998. PMID: 9871428 Clinical Trial.

10

The pharmacokinetic modelling of GI198745 (dutasteride), a compound with parallel linear and nonlinear elimination.

Gisleskog PO, Hermann D, Hammarlund-Udenaes M, Karlsson MO. Gisleskog PO, et al. Br J Clin Pharmacol. 1999 Jan;47(1):53-8. doi: 10.1046/j.1365-2125.1999.00843.x. Br J Clin Pharmacol. 1999. PMID: 10073740 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

139 results

Search Page

Filters